MAB 124I-omburtamab
Showing 26 - 50 of 306
Plasmodium Falciparum Infection, Malaria Trial in Faladje, Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal Saline)
Not yet recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS (VRC-MALMAB0114-00-AB)
- Normal Saline
-
Faladje, Région De Koulikoro, Mali
- +2 more
Apr 17, 2023
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Advanced or Metastatic Solid Tumors Trial (PMC-309 monotherapy, PMC-309 Dose Escalation in Combination with Pembrolizumab,
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- PMC-309 monotherapy
- +2 more
- (no location specified)
Jul 19, 2023
COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)
Not yet recruiting
- COVID-19, SARS-CoV-2
- Biological: AZD3152
- Biological: Placebo
-
Moscow, Russian Federation
- +5 more
Sep 26, 2023
Non-Hodgkin's Lymphoma, Myeloma, Active Solid Malignancy Trial in New York (PET Imaging using 124 IPUH71)
Active, not recruiting
- Non-Hodgkin's Lymphoma
- +2 more
- PET Imaging using 124 IPUH71
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)
Recruiting
- Rheumatoid Arthritis
- +8 more
- COVID-19 vaccine
-
Montréal, Quebec, Canada
- +1 more
Jan 13, 2023
Malaria Trial in Baltimore (MAM01, Placebo)
Not yet recruiting
- Malaria
- MAM01
- Placebo
-
Baltimore, MarylandCenter for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023
Cachexia Trial (AV-380)
Not yet recruiting
- Cachexia
- AV-380
- (no location specified)
May 9, 2023
Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)
Not yet recruiting
- Hepatitis b Virus
- HepB mAb19
- Sterile Saline
-
New York, New York
- +1 more
May 12, 2023
NPC Trial in Guangzhou (Sintilimab, IBI310)
Active, not recruiting
- NPC
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 3, 2022
Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)
Recruiting
- Breast Cancer
- Chidamide Plus Toripalimab Plus Paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 19, 2023
Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate
Recruiting
- Metastatic Prostate Cancer
- Liquid Biopsy
- Archival Tumor DNA sequencing
-
Barcelona, SpainSOLTI Cancer Research Group
May 22, 2023
Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)
Active, not recruiting
- Melanoma
- +2 more
- 124I-Humanized 3F8
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 1, 2022
Healthy Volunteers Trial in Shanghai (ZB001 for injection)
Not yet recruiting
- Healthy Volunteers
- ZB001 for injection
-
Shanghai, ChinaShanghai Mental Health Center
Sep 13, 2022
Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)
Not yet recruiting
- Advanced/Metastatic Solid Tumors
-
Kurralta Park, South Australia, Australia
- +1 more
Nov 9, 2022
Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)
Active, not recruiting
- Plasmodium Falciparum Infection
- Malaria
- VRC-MALMAB0100-00-AB (CIS43LS)
- Normal saline
-
Kalifabougou, Région De Koulikoro, Mali
- +1 more
Sep 20, 2022
Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)
Not yet recruiting
- Non Small Cell Lung Cancer
- Endostatin
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,
Active, not recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))
Withdrawn
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Elotuzumab, Selinexor, and Dexamethasone (ESd)
- (no location specified)
Apr 27, 2022
Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor
Recruiting
- Idiopathic Multicentric Castleman's Disease
- Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
- +2 more
-
Beijing, China
- +2 more
Apr 26, 2022
Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)
Recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS
- Normal Saline
-
Kisumu, KenyaKenya Medical Research Institute (KEMRI) Center for Global Healt
Sep 15, 2022
Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- W0101 - Cohort A1
- +2 more
-
Toulouse, France
- +2 more
Dec 19, 2022